Tetsuo Sasaki

In the pharmaceutical industry, which is undergoing a major shift from conventional batch production to continuous production, the development of PAT (Process Analysis Technology) for real-time monitoring of the manufacturing process has become a crucial issue. We aim to commercialize a compact, high-precision terahertz spectroscopy PAT tool by utilizing terahertz spectroscopy technology, which can accurately monitor crystallinity, a key factor in formulation quality. Achieving high-precision crystallinity evaluation in a narrow frequency band requires the integration of our uniquely developed spectroscopic equipment, the vast amount of spectral data we have accumulated over many years, and quantum chemical calculation technology. We are the only company that can provide these technologies and knowledge in an integrated manner, giving us a competitive advantage that other companies cannot easily imitate.